INTERNATIONAL PATENT: IGNIS THERAPEUTICS (SUZHOU) LIMITED FILES APPLICATION FOR "COMBINATION OF A NORADRENERGIC Α2A RECEPTOR AGONIST AND A NOREPINEPHRINE DOPAMINE REUPTAKE INHIBITOR AND USE THEREOF"

GENEVA, May 11 -- IGNIS THERAPEUTICS (SUZHOU) LIMITED (46F, BM InterContinental Business Center, 100 Yu Tong RoadJingan District, Shanghai 200070) filed a patent application (PCT/CN2024/128820) for "COMBINATION OF A NORADRENERGIC Alpha2A RECEPTOR AGONIST AND A NOREPINEPHRINE DOPAMINE REUPTAKE INHIBITOR AND USE THEREOF" on Oct 31, 2024. With publication no. WO/2025/092882, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Yishan (46F, BM InterContinental Business Center, 100 Yu Tong RoadJingan District, Shanghai 200070)...